Ranolazine-d8 (di hydrochloride)

Cat. No: CDIA-1986

CAS. No.: 1219802-60-4

Synonyms: CVT 303-dd8 (dihydrochloride); RS 43285-d8

Size: 500 μg

Price: Inquiry

Product Details
Formula	C24H27D8Cl2N3O4
Molecular Weight	508.51
Appearance	Solid
Purity	≥99.0%
Smiles String	CC(C=CC=C1C)=C1NC(CN(C([2H])([2H])C2([2H])[2H])C([2H])([2H])C([2H])([2H])N2CC(O)COC3=C(C=CC=C3)OC)=O.[H]Cl.[H]Cl

Storage & Handling
Shipping	Room temperature.
Storage	4 °C, sealed storage, away from moisture *In solvent : -80 °C, 6 months; -20 °C, 1 month (sealed storage, away from moisture)

Description

Ranolazine-d8 (dihydrochloride) is the deuterium labeled Ranolazine dihydrochloride. Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP). Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor.

! For research use only. Not intended for any clinical use.